BackLexeo Therapeutics Overview

Lexeo Therapeutics Common Stock

Lexeo Therapeutics's common stock is $8K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$8000.00
↑ 60.00% YoYΔ $3000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Lexeo Therapeutics Common Stock History

Loading

Lexeo Therapeutics vs. peers: Common Stock Comparison

Loading

Lexeo Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Lexeo Therapeutics (LXEO) FAQ

As of the most recent data (June 2026), LXEO shows a common stock of $8K. That compares with $5K in the prior-year period — up 60.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LXEO's common stock is now $8K (was $5K) — a 60.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Lexeo Therapeutics is outperforming or lagging.

Tracking LXEO's common stock over time shows whether Lexeo Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $8K That compares with $5K in the prior-year period — up 60.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Lexeo Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $8K) with ownership activity and broader fundamentals.